Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery
- Conditions
- Epiretinal MembraneCataract Senile
- Registration Number
- NCT03045367
- Lead Sponsor
- Clinica Oculistica dell'Università di Torino
- Brief Summary
This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- age > 55 years
- visual acuity ≤ 20/40
- idiopathic epiretinal membrane
- cataract
- Amsler test positive for metamorphopsia.
- previous ocular interventions
- other ocular diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Area of central scotoma Change in area of central scotoma from baseline at 180 days Change in area, in square pixel, of central scotoma
Visual Acuity Change in visual acuity from baseline at 180 days Change in LogMAR visual acuity
Central fovea thickness Change in fovea thickness from baseline at 180 days Change in fovea thickness in µm at the Sd OCT
Metamorphopsia Change in metamorphopsia from baseline at 180 days. Change in spatial degree of distortion perception
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.